跳至主要内容
临床试验/ACTRN12607000366459
ACTRN12607000366459招募中未知

An Observational Study of Acquired Viral Mutations in Chronic Hepatitis B Patients on Antihepadnaviral Therapy.

Gilead Sciences Pty Ltd0 个研究点目标入组 800 人开始时间: 2007年7月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Provided informed consent-Diagnosis of chronic hepatitis B (HBsAg documented for at least 6 months)-Currently prescribed antihepadnaviral therapy (including, but not limited to: lamivudine, adefovir, entecavir, tenofovir or telbivudine) for chronic hepatitis B management-Been taking current antihepadnaviral therapy for at least 6 months prior to recruitment-Negative tests for HIV Ab, Hepatitis C Ab and Hepatitis D Ab within the previous 2 yearsKey

排除标准

  • Known or suspected co-infection with HIV, Hepatitis C or Hepatitis D-Concomitant immunosuppression / immunomodulator therapies-Diagnosis of hepatocellular carcinoma where anticipated life expectancy is less than 6 months-Current participation in an interventional, blinded, pharmaceutical industry-sponsored clinical trial -Current Child Pugh class C classification (current Child Pugh score > 9)-Other known or suspected cause of chronic liver disease-Any other reason that, in the investigator’s opinion, participation in the study would not be in the participant’s best interest.

研究者

相似试验

招募中
不适用
A study of the incidence of molecular mutations in newly diagnosed acute lymphoblastic leukemia (ALL) patients by Next-generation sequencing techniqueThai newly diagnosed ALL patients aged greater than 18 years.Acute lymphoblastic leukemia, Next-generation sequencing ,Molecular mutations
TCTR20240409003Siriraj Hospital Mahidol University140
已完成
不适用
Observation of occurrence of Host and Viral Genotypes in Patients withChronic Hepatitis C and Chronic Hepatitis B Infection in India
CTRI/2012/08/002936Gilead Sciences Inc1,000
尚未招募
不适用
A study of incidence of molecular mutations in newly diagnosed acute myeloid leukemia (AML) patients by Next-generation sequencing techniqueewly diagnosed acute myeloid leukemia aged greater than 18 yearsAcute myeloid leukemia, molecular, incidence, next-generation sequencing
TCTR20190227003The organization takes responsibility for initiating a study.139
进行中(未招募)
不适用
A study to assess the incidence in the UK of a change in a protein found in patients with newly diagnosed non-small cell lung cancer which has advanced or spread, and to investigate the quality of life of these patients when they receive treatment with erlotinib (Tarceva®) alone as a first treatment for this stage of their disease.
EUCTR2010-021120-96-GBRoche Products Limited1,200
招募中
不适用
Observational study on gene mutation and prognosis for patients with resectable pancreatic cancerpancreatic cancer
JPRN-UMIN000032917Kobe university219